ES462065A1 - Procedimiento para la preparacion de derivados de tiazolidi-na. - Google Patents

Procedimiento para la preparacion de derivados de tiazolidi-na.

Info

Publication number
ES462065A1
ES462065A1 ES462065A ES462065A ES462065A1 ES 462065 A1 ES462065 A1 ES 462065A1 ES 462065 A ES462065 A ES 462065A ES 462065 A ES462065 A ES 462065A ES 462065 A1 ES462065 A1 ES 462065A1
Authority
ES
Spain
Prior art keywords
thiazolidine derivatives
medicines
meanings
substituents
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES462065A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES462065A1 publication Critical patent/ES462065A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Procedimiento para la preparación de derivados de tiazolidina de la fórmula general I ***(Ver fórmula I) en la que R1 significa hidrógeno, un grupo metilo, halógeno, trifluormetilo o un grupo alcoxi con 1 a 3 átomos de carbono, R2 significa hidrógeno, un grupo metilo, halógeno o un grupo nitro, R3 y R4 significan radicales alcohilo o alquenilo con 1 a 4 átomos de carbono, radicales fenilalcohilo con 1 a 2 átomos de carbono en la porción alcohólica.
ES462065A 1976-09-08 1977-09-02 Procedimiento para la preparacion de derivados de tiazolidi-na. Expired ES462065A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762640358 DE2640358A1 (de) 1976-09-08 1976-09-08 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES462065A1 true ES462065A1 (es) 1978-06-01

Family

ID=5987411

Family Applications (1)

Application Number Title Priority Date Filing Date
ES462065A Expired ES462065A1 (es) 1976-09-08 1977-09-02 Procedimiento para la preparacion de derivados de tiazolidi-na.

Country Status (20)

Country Link
US (1) US4174397A (es)
JP (1) JPS5334771A (es)
AT (2) AT365181B (es)
AU (1) AU509651B2 (es)
BE (1) BE858520A (es)
CA (1) CA1089458A (es)
DE (1) DE2640358A1 (es)
DK (1) DK397777A (es)
ES (1) ES462065A1 (es)
FI (1) FI772642A (es)
FR (1) FR2364219A1 (es)
GB (1) GB1592272A (es)
HU (1) HU175751B (es)
IT (1) IT1084414B (es)
NL (1) NL7709697A (es)
NO (1) NO773094L (es)
NZ (1) NZ185105A (es)
PT (1) PT67014B (es)
SE (1) SE7710084L (es)
ZA (1) ZA775405B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210039A (ja) * 1983-05-16 1984-11-28 Kirin Brewery Co Ltd ２−ブロモ−１−テトラロン誘導体およびその用途
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
CA1341370C (en) * 1988-04-28 2002-06-18 John J. Powinski Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
DE19736921A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Cyanoindan-1-onen
DE19736922A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Halogenindan-1-onen
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908538A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908537A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908536A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE50003761D1 (de) 1999-11-05 2003-10-23 Aventis Pharma Gmbh Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
PL357547A1 (en) 2000-02-23 2004-07-26 Aventis Pharma Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2001062747A1 (de) * 2000-02-26 2001-08-30 Aventis Pharma Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
JP6204583B2 (ja) * 2014-05-15 2017-09-27 富士フイルム株式会社 α−ブロモアセトフェノン化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT67014B (de) 1979-05-14
GB1592272A (en) 1981-07-01
FR2364219B1 (es) 1980-06-20
AU2865777A (en) 1979-03-15
NZ185105A (en) 1979-12-11
ZA775405B (en) 1978-07-26
IT1084414B (it) 1985-05-25
PT67014A (de) 1977-09-30
JPS5334771A (en) 1978-03-31
SE7710084L (sv) 1978-03-09
FI772642A (fi) 1978-03-09
FR2364219A1 (fr) 1978-04-07
NL7709697A (nl) 1978-03-10
AU509651B2 (en) 1980-05-22
ATA171881A (de) 1984-01-15
DE2640358A1 (de) 1978-03-16
HU175751B (hu) 1980-10-28
CA1089458A (en) 1980-11-11
BE858520A (fr) 1978-03-08
US4174397A (en) 1979-11-13
ATA643577A (de) 1981-05-15
DK397777A (da) 1978-03-09
AT365181B (de) 1981-12-28
NO773094L (no) 1978-03-09

Similar Documents

Publication Publication Date Title
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
ES459405A1 (es) Un procedimiento para la preparacion de un compuesto de pi- perazinilpirazina.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
SE7411243L (es)
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ES8308549A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
GB1148214A (en) Heterocyclic guanidine derivatives
ES8308545A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES477303A1 (es) Procedimiento para la preparacion de bencenosulfonilureas.
ES481271A1 (es) Procedimiento de preparacion de derivados de la l-cisteina.
ES461971A1 (es) Procedimiento para la preparacion de acidos benzoicos.
ES430131A1 (es) Procedimiento para preparar n'-(aminoacilaminofenil)-aceta- midinas.
ES439180A1 (es) Procedimiento para la preparacion de derivados de piperido- na.
ES473689A1 (es) Un procedimiento de preparacion de un derivado del floroglu-cinol.
ES410668A2 (es) Un procedimiento para la preparacion de composiciones her- bicidas a base de derivados de aminoacido n,n-disustituidos.
GB849755A (en) Pharmaceutical preparations comprising ª‡-dialkylamino-propiophenones
ES455692A1 (es) Procedimiento para la produccion de derivados de alquilen- dioxipiperacina.
ES403476A1 (es) Procedimiento para la preparacion de 2-arilamino - imidazo-linas - (2) sustituidas.